Bausch Health Companies Inc.
0.00%
0
885590
071734107
Aug 13, 2025
Aug 15, 2025, 09:39 AM
Reporting Persons (10)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Icahn Partners Master Fund LP | Partnership | 0.00% | 0 | 0 | 0 |
| Icahn Offshore LP | Partnership | 0.00% | 0 | 0 | 0 |
| Icahn Partners LP | Partnership | 0.00% | 0 | 0 | 0 |
| Icahn Onshore LP | Partnership | 0.00% | 0 | 0 | 0 |
| Icahn Capital LP | Partnership | 0.00% | 0 | 0 | 0 |
| IPH GP LLC | Partnership | 0.00% | 0 | 0 | 0 |
| Icahn Enterprises Holdings L.P. | Partnership | 0.00% | 0 | 0 | 0 |
| Icahn Enterprises G.P. Inc. | CO | 0.00% | 0 | 0 | 0 |
| Beckton Corp. | CO | 0.00% | 0 | 0 | 0 |
| Carl C. Icahn | Individual | 0.00% | 0 | 0 | 0 |
Disclosure Items (2)
Common Stock, no par value
Bausch Health Companies Inc.
2150 ST. ELZEAR BLVD. WEST, QUEBEC, A8, H7L 4A8
As a result of the transactions reported in this Schedule 13D, the Reporting Persons may be deemed to beneficially own 0 Shares.
As a result of the transactions reported in this Schedule 13D, the Reporting Persons may be deemed to beneficially own 0 Shares.
On August 14, 2025, Icahn Partners LP sold 20,297,523 Shares and Icahn Partners Master Fund LP sold 14,423,595 Shares, in each case at a price of $9.00 per share (including brokerage fees).
As a result of the transactions reported in this Schedule 13D, the Reporting Persons ceased to be the beneficial owners of more than five percent of the Shares and are no longer subject to the reporting requirements of Rule 13d-1(a) of the Exchange Act.